FDA Import Refusal 112-1603077-1/1/1 — Shandong Anxin Pharmaceutical Co., Ltd.
The FDA refused shipment 112-1603077-1/1/1 from Shandong Anxin Pharmaceutical Co., Ltd. (China) on April 15, 2013. The refused product falls under Drugs and Biologics — HYDROXYUREA (ANTI-NEOPLASTIC). Cited charge: 16 This firm has 1 other import refusal on record.
Refusal Details
- Date
- April 15, 2013
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 62ICT24 HYDROXYUREA (ANTI-NEOPLASTIC)
- Charges
- 16